PDLIM7 and neoplasm: In murine models, adoptive transfer of LMP1‐TCR‐engineered T cells delayed tumour progression and extended survival, overcoming challenges like low availability of LMP1‐CTLs and high LMP1‐associated cytotoxicity [60].